374 related articles for article (PubMed ID: 32332097)
1. Inhibition of the epigenetic suppressor EZH2 primes osteogenic differentiation mediated by BMP2.
Dudakovic A; Samsonraj RM; Paradise CR; Galeano-Garces C; Mol MO; Galeano-Garces D; Zan P; Galvan ML; Hevesi M; Pichurin O; Thaler R; Begun DL; Kloen P; Karperien M; Larson AN; Westendorf JJ; Cool SM; van Wijnen AJ
J Biol Chem; 2020 Jun; 295(23):7877-7893. PubMed ID: 32332097
[TBL] [Abstract][Full Text] [Related]
2. Combination of BMP2 and EZH2 Inhibition to Stimulate Osteogenesis in a 3D Bone Reconstruction Model.
Lui H; Samsonraj RM; Vaquette C; Denbeigh J; Kakar S; Cool SM; Dudakovic A; van Wijnen AJ
Tissue Eng Part A; 2021 Aug; 27(15-16):1084-1098. PubMed ID: 33234056
[TBL] [Abstract][Full Text] [Related]
3. G-protein coupled receptor 5C (GPRC5C) is required for osteoblast differentiation and responds to EZH2 inhibition and multiple osteogenic signals.
Dashti P; Thaler R; Hawse JR; Galvan ML; van der Eerden BJ; van Wijnen AJ; Dudakovic A
Bone; 2023 Nov; 176():116866. PubMed ID: 37558192
[TBL] [Abstract][Full Text] [Related]
4. Enhancer of zeste homolog 2 (
Dudakovic A; Camilleri ET; Paradise CR; Samsonraj RM; Gluscevic M; Paggi CA; Begun DL; Khani F; Pichurin O; Ahmed FS; Elsayed R; Elsalanty M; McGee-Lawrence ME; Karperien M; Riester SM; Thaler R; Westendorf JJ; van Wijnen AJ
J Biol Chem; 2018 Aug; 293(33):12894-12907. PubMed ID: 29899112
[TBL] [Abstract][Full Text] [Related]
5. Multiple pharmacological inhibitors targeting the epigenetic suppressor enhancer of zeste homolog 2 (Ezh2) accelerate osteoblast differentiation.
Galvan ML; Paradise CR; Kubrova E; Jerez S; Khani F; Thaler R; Dudakovic A; van Wijnen AJ
Bone; 2021 Sep; 150():115993. PubMed ID: 33940225
[TBL] [Abstract][Full Text] [Related]
6. Enhancer of Zeste Homolog 2 Inhibition Stimulates Bone Formation and Mitigates Bone Loss Caused by Ovariectomy in Skeletally Mature Mice.
Dudakovic A; Camilleri ET; Riester SM; Paradise CR; Gluscevic M; O'Toole TM; Thaler R; Evans JM; Yan H; Subramaniam M; Hawse JR; Stein GS; Montecino MA; McGee-Lawrence ME; Westendorf JJ; van Wijnen AJ
J Biol Chem; 2016 Nov; 291(47):24594-24606. PubMed ID: 27758858
[TBL] [Abstract][Full Text] [Related]
7. EZH2 or HDAC1 Inhibition Reverses Multiple Myeloma-Induced Epigenetic Suppression of Osteoblast Differentiation.
Adamik J; Jin S; Sun Q; Zhang P; Weiss KR; Anderson JL; Silbermann R; Roodman GD; Galson DL
Mol Cancer Res; 2017 Apr; 15(4):405-417. PubMed ID: 28119431
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2.
Dudakovic A; Camilleri ET; Xu F; Riester SM; McGee-Lawrence ME; Bradley EW; Paradise CR; Lewallen EA; Thaler R; Deyle DR; Larson AN; Lewallen DG; Dietz AB; Stein GS; Montecino MA; Westendorf JJ; van Wijnen AJ
J Biol Chem; 2015 Nov; 290(46):27604-17. PubMed ID: 26424790
[TBL] [Abstract][Full Text] [Related]
9. Benzo[a]pyrene injures BMP2-induced osteogenic differentiation of mesenchymal stem cells through AhR reducing BMPRII.
An L; Shi Q; Fan M; Huang G; Zhu M; Zhang M; Liu Y; Weng Y
Ecotoxicol Environ Saf; 2020 Oct; 203():110930. PubMed ID: 32684523
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Ezh2 redistributes bivalent domains within transcriptional regulators associated with WNT and Hedgehog pathways in osteoblasts.
Carrasco ME; Thaler R; Nardocci G; Dudakovic A; van Wijnen AJ
J Biol Chem; 2023 Sep; 299(9):105155. PubMed ID: 37572850
[TBL] [Abstract][Full Text] [Related]
11. The lysine methyltransferases SET and MYND domain containing 2 (Smyd2) and Enhancer of Zeste 2 (Ezh2) co-regulate osteoblast proliferation and mineralization.
Dashti P; van de Peppel J; Thaler R; Paradise CR; Stein GS; Montecino MA; van Leeuwen JPTM; van der Eerden BJ; Dudakovic A; van Wijnen AJ
Gene; 2023 Jan; 851():146928. PubMed ID: 36191822
[TBL] [Abstract][Full Text] [Related]
12. Blocking EZH2 methylation transferase activity by GSK126 decreases stem cell-like myeloma cells.
Zeng D; Liu M; Pan J
Oncotarget; 2017 Jan; 8(2):3396-3411. PubMed ID: 27926488
[TBL] [Abstract][Full Text] [Related]
13. Fucoidan promotes osteoblast differentiation via JNK- and ERK-dependent BMP2-Smad 1/5/8 signaling in human mesenchymal stem cells.
Kim BS; Kang HJ; Park JY; Lee J
Exp Mol Med; 2015 Jan; 47(1):e128. PubMed ID: 25572360
[TBL] [Abstract][Full Text] [Related]
14. Osteogenic Stimulation of Human Adipose-Derived Mesenchymal Stem Cells Using a Fungal Metabolite That Suppresses the Polycomb Group Protein EZH2.
Samsonraj RM; Dudakovic A; Manzar B; Sen B; Dietz AB; Cool SM; Rubin J; van Wijnen AJ
Stem Cells Transl Med; 2018 Feb; 7(2):197-209. PubMed ID: 29280310
[TBL] [Abstract][Full Text] [Related]
15. 1,25(OH)2D3 inhibits osteogenic differentiation through activating β‑catenin signaling via downregulating bone morphogenetic protein 2.
Han X; Zhu N; Wang Y; Cheng G
Mol Med Rep; 2020 Dec; 22(6):5023-5032. PubMed ID: 33173996
[TBL] [Abstract][Full Text] [Related]
16. 3,5-dicaffeoyl‑epi-quinic acid from Atriplex gmelinii enhances the osteoblast differentiation of bone marrow-derived human mesenchymal stromal cells via WnT/BMP signaling and suppresses adipocyte differentiation via AMPK activation.
Karadeniz F; Oh JH; Lee JI; Seo Y; Kong CS
Phytomedicine; 2020 Jun; 71():153225. PubMed ID: 32464299
[TBL] [Abstract][Full Text] [Related]
17. EZH2 Inhibitor GSK126 Suppresses Antitumor Immunity by Driving Production of Myeloid-Derived Suppressor Cells.
Huang S; Wang Z; Zhou J; Huang J; Zhou L; Luo J; Wan YY; Long H; Zhu B
Cancer Res; 2019 Apr; 79(8):2009-2020. PubMed ID: 30737232
[TBL] [Abstract][Full Text] [Related]
18. Polydatin promotes the osteogenic differentiation of human bone mesenchymal stem cells by activating the BMP2-Wnt/β-catenin signaling pathway.
Chen XJ; Shen YS; He MC; Yang F; Yang P; Pang FX; He W; Cao YM; Wei QS
Biomed Pharmacother; 2019 Apr; 112():108746. PubMed ID: 30970530
[TBL] [Abstract][Full Text] [Related]
19. 5'-hydroxy Auraptene stimulates osteoblast differentiation of bone marrow-derived mesenchymal stem cells via a BMP-dependent mechanism.
Abdallah BM; Ali EM
J Biomed Sci; 2019 Jul; 26(1):51. PubMed ID: 31277646
[TBL] [Abstract][Full Text] [Related]
20. BST2 Mediates Osteoblast Differentiation via the BMP2 Signaling Pathway in Human Alveolar-Derived Bone Marrow Stromal Cells.
Yoo SH; Kim JG; Kim BS; Lee J; Pi SH; Lim HD; Shin HI; Cho ES; You HK
PLoS One; 2016; 11(6):e0158481. PubMed ID: 27359105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
